Bionano reports second quarter 2025 results and highlights recent business progress

San diego, aug. 14, 2025 (globe newswire) -- bionano genomics, inc. (nasdaq: bngo) today reported financial results for the second quarter ended june 30, 2025. “we continued to execute on our new strategy of focusing on our base of routine users of optical genome mapping (ogm) and via™ software as the primary drivers of our revenue and gross profit in the second quarter.
BNGO Ratings Summary
BNGO Quant Ranking